Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 2
2012 2
2013 3
2014 4
2015 2
2017 2
2018 7
2019 4
2020 3
2021 11
Text availability
Article attribute
Article type
Publication date

Search Results

36 results
Results by year
Filters applied: . Clear all
Page 1
One-year treatment outcomes of secukinumab versus tumor necrosis factor inhibitors in Spondyloarthritis.
Glintborg B, Lindstrom U, Di Giuseppe D, Provan SA, Gudbjornsson B, Hetland ML, Michelsen B, Wallman J, Aaltonen K, Hokkanen AM, Nordström D, Jørgensen TS, Hansen RL, Jon Geirsson A, Grøn K, Krogh NS, Askling J, Kristensen LE, Jacobsson L; DANBIO (Denmark), ARTIS/SRQ (Sweden), ICEBIO (Iceland), ROB-FIN (Finland), NOR-DMARD (Norway) registries. Glintborg B, et al. Among authors: di giuseppe d. Arthritis Care Res (Hoboken). 2020 Nov 30. doi: 10.1002/acr.24523. Online ahead of print. Arthritis Care Res (Hoboken). 2020. PMID: 33253491
Opportunities and challenges for real-world studies on chronic inflammatory joint diseases through data enrichment and collaboration between national registers: the Nordic example.
Chatzidionysiou K, Hetland ML, Frisell T, Di Giuseppe D, Hellgren K, Glintborg B, Nordström D, Aaltonen K, Törmänen MR, Klami Kristianslund E, Kvien TK, Provan SA, Björn Guðbjörnsson B, Dreyer L, Kristensen LE, Jørgensen TS, Jacobsson L, Askling J. Chatzidionysiou K, et al. Among authors: di giuseppe d. RMD Open. 2018 Apr 12;4(1):e000655. doi: 10.1136/rmdopen-2018-000655. eCollection 2018. RMD Open. 2018. PMID: 29682328 Free PMC article. Review.
Uptake of rheumatology biosimilars in the absence of forced switching.
Di Giuseppe D, Frisell T, Ernestam S, Forsblad-D'Elia H, Lindqvist E, Lindström U, Sjöwall C, Askling J; ARTIS group. Di Giuseppe D, et al. Expert Opin Biol Ther. 2018 May;18(5):499-504. doi: 10.1080/14712598.2018.1458089. Epub 2018 Apr 10. Expert Opin Biol Ther. 2018. PMID: 29633865 Free article.
Inflammatory hallmarks of lesser prominence in psoriatic arthritis patients starting biologics: a Nordic population-based cohort study.
Lund Hansen R, Schoedt Jørgensen T, Dreyer L, Hetland ML, Glintborg B, Askling J, Di Giuseppe D, Jacobsson LTH, Wallman JK, Nordstrom D, Aaltonen K, Kristianslund EK, Kvien TK, Provan SA, Gudbjornsson B, Love TJ, Kristensen LE. Lund Hansen R, et al. Among authors: di giuseppe d. Rheumatology (Oxford). 2021 Jan 5;60(1):140-146. doi: 10.1093/rheumatology/keaa237. Rheumatology (Oxford). 2021. PMID: 32591790
Comparison of treatment retention and response to secukinumab versus tumour necrosis factor inhibitors in psoriatic arthritis.
Lindström U, Glintborg B, Di Giuseppe D, Schjødt Jørgensen T, Gudbjornsson B, Lederballe Grøn K, Aarrestad Provan S, Michelsen B, Lund Hetland M, Wallman JK, Nordström D, Trokovic N, Love TJ, Krogh NS, Askling J, Jacobsson LTH, Kristensen LE. Lindström U, et al. Among authors: di giuseppe d. Rheumatology (Oxford). 2021 Aug 2;60(8):3635-3645. doi: 10.1093/rheumatology/keaa825. Rheumatology (Oxford). 2021. PMID: 33367900
36 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page